Cassandra D Benge1, John Alan Barwise1. 1. is a Clinical Pharmacy Specialist, and is a Staff Physician and Medical Director of the Surgical Intensive Care Unit, both at VA Tennessee Valley Healthcare System in Nashville. John Barwise is Associate Professor of Clinical Anesthesiology at Vanderbilt University Medical Center in Nashville.
Abstract
BACKGROUND: Aerosolized medications are frequently administered across the health care continuum to acutely ill patients. During viral pandemics, the World Health Organization and the Centers for Disease Control and Prevention advise the application of airborne precautions when performing aerosol-generating medical procedures, such as aerosolized medications. OBSERVATIONS: Appropriate personal protective equipment (PPE), including fit-tested particulate respirators should be worn when administering nebulized medications to patients. These PPEs have been in short supply in the US during early phases of the COVID-19 pandemic, which is increasing the risk faced by health care workers (HCWs) who are treating patients using aerosolized medications. Despite taking appropriate precautions, HCWs are becoming infected with COVID-19. This may be related to secondary exposure related to viral longevity in fugitive emissions and viability on fomites. CONCLUSIONS: We have expanded on non-US public health recommendations to provide guidance to frontline HCWs to enhance collaboration between clinicians, who are often siloed in their clinical practices, and ultimately to protect the federal workforce, which cannot sustain a significant loss of frontline HCWs.
BACKGROUND: Aerosolized medications are frequently administered across the health care continuum to acutely ill patients. During viral pandemics, the World Health Organization and the Centers for Disease Control and Prevention advise the application of airborne precautions when performing aerosol-generating medical procedures, such as aerosolized medications. OBSERVATIONS: Appropriate personal protective equipment (PPE), including fit-tested particulate respirators should be worn when administering nebulized medications to patients. These PPEs have been in short supply in the US during early phases of the COVID-19 pandemic, which is increasing the risk faced by health care workers (HCWs) who are treating patients using aerosolized medications. Despite taking appropriate precautions, HCWs are becoming infected with COVID-19. This may be related to secondary exposure related to viral longevity in fugitive emissions and viability on fomites. CONCLUSIONS: We have expanded on non-US public health recommendations to provide guidance to frontline HCWs to enhance collaboration between clinicians, who are often siloed in their clinical practices, and ultimately to protect the federal workforce, which cannot sustain a significant loss of frontline HCWs.
Authors: Darren B Taichman; Joe Ornelas; Lorinda Chung; James R Klinger; Sandra Lewis; Jess Mandel; Harold I Palevsky; Stuart Rich; Namita Sood; Erika B Rosenzweig; Terence K Trow; Rex Yung; C Gregory Elliott; David B Badesch Journal: Chest Date: 2014-08 Impact factor: 9.410
Authors: Shawna L Strickland; Bruce K Rubin; Carl F Haas; Teresa A Volsko; Gail S Drescher; Catherine A O'Malley Journal: Respir Care Date: 2015-07 Impact factor: 2.258
Authors: Mark J D Griffiths; Danny Francis McAuley; Gavin D Perkins; Nicholas Barrett; Bronagh Blackwood; Andrew Boyle; Nigel Chee; Bronwen Connolly; Paul Dark; Simon Finney; Aemun Salam; Jonathan Silversides; Nick Tarmey; Matt P Wise; Simon V Baudouin Journal: BMJ Open Respir Res Date: 2019-05-24
Authors: Tze-wai Wong; Chin-kei Lee; Wilson Tam; Joseph Tak-fai Lau; Tak-sun Yu; Siu-fai Lui; Paul K S Chan; Yuguo Li; Joseph S Bresee; Joseph J Y Sung; Umesh D Parashar Journal: Emerg Infect Dis Date: 2004-02 Impact factor: 6.883
Authors: Margarete Pierce; Steven W Gudowski; Karsten J Roberts; Anthony Jackominic; Karen K Zumstein; Amanda Shuttleworth; Joshua Ho; Phillip Susser; Alomi Parikh; John M Chandler; Ann Marie Huffenberger; Michael J Scott; C William Hanson; Krzysztof Laudanski Journal: J Clin Med Date: 2022-01-29 Impact factor: 4.241